Tempest Therapeutics Inc. (referred to as Tempest) recently disclosed a strategic collaboration regarding its core candidate drug Tpst-2003.

Fintech startup Tytl recently announced the completion of a strategic financing round led by Strobe and Fifth Era.

Solid Biosciences (SLDB) recently disclosed that the company plans to hold a follow-up meeting with the U.S. Food and Drug Administration (FDA) in the first half of 2026, aiming to obtain further guidance on the potential accelerated approval pathway for its gene therapy SGT-003.

In the past 24 hours, the MarketVectorTM Digital Assets 100 Small Cap Index fell by 2.61%, currently at 2633.29 points, remaining mostly stable around 2620 points during the period—experiencing a narrow range of fluctuations at a low level.

FDIC official Hill: The U.S. backstop does not apply to stablecoins